Journal of Substance Abuse Treatment

Papers
(The H4-Index of Journal of Substance Abuse Treatment is 30. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-07-01 to 2025-07-01.)
ArticleCitations
C2: editorial board116
JSAT call for papers for special issue: Stimulant use disorder98
Barriers to accessing treatment for substance use after inpatient managed withdrawal (Detox): A qualitative study83
The impact of military sexual trauma and gender on receipt of evidence-based medication treatment among veterans with opioid use disorder81
Augmenting substance use treatment in the drug court: A pilot randomized trial of peer recovery support71
Hepatitis C treatment outcomes among patients treated in co-located primary care and addiction treatment settings63
Substance use disorders among older populations: What role do race and ethnicity play in treatment and completion?56
A clinical protocol of a comparative effectiveness trial of extended-release naltrexone versus extended-release buprenorphine with individuals leaving jail55
Community perspectives on supervised consumption sites: Insights from four U.S. counties deeply affected by opioids50
A qualitative study of service engagement and unmet needs among unstably housed people who inject drugs in Massachusetts49
Integrating substance use care into primary care for adolescents and young adults: Lessons learned49
Perspectives on electronic portal use among patients treated with medications for opioid use disorder in primary care48
The new services that opioid treatment programs have adopted in response to COVID-1947
C2: editorial board47
Sex-based differences in psychiatric symptoms and opioid abstinence during buprenorphine/naloxone treatment in adolescents with opioid use disorders45
Examining differences in retention on medication for opioid use disorder: An analysis of Ohio Medicaid data44
Life satisfaction among individuals with opioid use disorder receiving extended-release naltrexone: A 12-week randomized controlled trial and a 36-week follow-up42
Views of barriers and facilitators to continuing methadone treatment upon release from jail among people receiving patient navigation services42
Uncommon and preventable: Perceptions of diversion of medication for opioid use disorder in jail42
Education and careers were our way out39
Experiences of stigma among individuals in recovery from opioid use disorder in a rural setting: A qualitative analysis39
Serial mediation analysis of treatment-specific processes in two contrasting alcohol treatments38
Suicide safer care in behavioral health settings: A comparative analysis of perceptions, training completion, and practice between mental health and substance use disorder treatment providers38
C2: editorial board36
Al-Anon Intensive Referral (AIR): A qualitative formative evaluation for implementation33
Massachusetts Justice Community Opioid Innovation Network (MassJCOIN)33
What is the relapse risk during treatment? Survivor analysis of single and multiple relapse events in inpatients with alcohol use disorder as part of an observational study32
Use of non–prescribed buprenorphine in the criminal justice system: Perspectives of individuals recently released from incarceration31
A randomized clinical trial evaluating the impact of counselor training and patient feedback on substance use disorder patients' sexual risk behavior30
What is success in treatment for opioid use disorder? Perspectives of physicians and patients in primary care settings30
Incarceration and compulsory rehabilitation impede use of medication for opioid use disorder and HIV care engagement in Vietnam30
Emergency department interventions for opioid use disorder: A synthesis of emerging models30
Association between industry sponsorship and author conflicts of interest with outcomes of systematic reviews and meta-analyses of interventions for opioid use disorder30
0.060477018356323